Evolving paradigms in valvular heart disease: where should guidelines move?
November 15, 2019 | 10.4244/EIJ-D-19-00818
Showing 1-20 of 35 articles
Coronary interventions
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions October 18, 2019 | 10.4244/EIJ-D-18-00292
Interventions for stroke
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism January 18, 2019 | 10.4244/EIJ-D-18-00622
Coronary interventions
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study December 7, 2018 | 10.4244/EIJ-D-18-00491
Stents and scaffolds
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial) January 19, 2018 | 10.4244/EIJ-D-17-00873
Coronary interventions
Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry September 20, 2017 | 10.4244/EIJ-D-17-00078
Coronary interventions
EAPCI registries: a first step towards systematic monitoring of European interventional cardiology practice May 15, 2017 | 10.4244/EIJV13IZA1
Coronary interventions
Current trends in coronary interventions: an overview from the EAPCI registries May 15, 2017 | 10.4244/EIJV13IZA2
Interventions for valvular disease
Current trends in structural heart interventions: an overview of the EAPCI registries May 15, 2017 | 10.4244/EIJV13IZA3
Coronary interventions
Poland: coronary and structural heart interventions from 2010 to 2015 May 15, 2017 | 10.4244/EIJ-D-16-00836
Percutaneous coronary intervention for acute myocardial infarction
November 16, 2016
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective
May 19, 2015 | 10.4244/EIJY15M01_05
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)
November 29, 2013 | 10.4244/EIJV9I7A135
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
October 25, 2013 | 10.4244/EIJV9I6A115
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial
June 28, 2013 | 10.4244/EIJV9I2A37
Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology
March 22, 2013 | 10.4244/EIJV8I11A192